James Sabry Departs Roche After 14 Years, Returns to Biotech Industry

1. James Sabry's Departure: After 14 years, James Sabry is leaving his position as Global Head of Pharma Partnering at Roche/Genentech to return to the biotech industry.
2. Career Background: Sabry has a diverse background in science, medicine, and business. He holds an M.D. from Queen's University, an M.Sc. in Biology from California Institute of Technology, and a Ph.D. in Neuroscience from the University of California, San Francisco.
3. Previous Roles: Sabry co-founded Cytokinetics, served as President and CEO of Arete Therapeutics, and held various leadership positions at Genentech and Roche, including Global Head of Pharma Partnering.
4. Industry Impact: Sabry is known for his significant contributions to the biotech industry, particularly in the area of partnering and deal-making.
5. Future Plans: Sabry is set to return to the US biotech scene, marking a new chapter in his career.